While higher densities of CD8+ T cells are typically associated with a favourable prognosis in other tumor types, higher densities of both CD8+ and CD4+ cells have been shown to be poor prognostic factors in prostate cancer [8, 13–16]. This evidence concerns the gene CD8A and prostate carcinoma.